Last updated on August 2020

Lynparza Breast Cancer Clinical Experience Investigation

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Breast Cancer
  • Age: - 100 Years
  • Gender: Male or Female

Inclusion Criteria:

  • Unresectable or recurrent BRCA mutated HER2 negative breast cancer with prior anticancer chemotherapy

Exclusion Criteria:

  • The patients who are not started on Lymparza for the first time

Recruitment Status: Closed

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.